Skip to content

Drug interactions

Finerenone + Zafirlukast

Severity: Moderate

Finerenone and Zafirlukast: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Zafirlukast is a weak CYP3A4 inhibitor and may modestly raise finerenone concentrations. Higher finerenone exposure increases the risk of hyperkalemia and renal function changes.

What this interaction means in plain words

Finerenone and Zafirlukast can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Finerenone belongs to Cardiovascular; Zafirlukast belongs to Respiratory.

Evidence level: Low

Why it happens

Zafirlukast weakly inhibits CYP3A4, reducing the first-pass and systemic metabolism of finerenone.

What to do

Check serum potassium and renal function after starting zafirlukast and during dose changes. Adjust finerenone dosing according to potassium results.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Finerenone and Zafirlukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Finerenone with Zafirlukast?

MediHelp rates the interaction as moderate. Finerenone and Zafirlukast can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Zafirlukast is a weak CYP3A4 inhibitor and may modestly raise finerenone concentrations. Higher finerenone exposure increases the risk of hyperkalemia and renal function changes.

How serious is the interaction between Finerenone and Zafirlukast?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check serum potassium and renal function after starting zafirlukast and during dose changes. Adjust finerenone dosing according to potassium results.

What other medicines interact with Zafirlukast?

MediHelp also lists interactions of Zafirlukast with, for example, Pimozide, Lomitapide, Nilotinib. The full list is on the Zafirlukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in